Ibere Pharmaceuticals (NYSE:IBER) Sees Large Increase in Short Interest

Ibere Pharmaceuticals (NYSE:IBER) saw a large increase in short interest during the month of September. As of September 30th, there was short interest totalling 1,800 shares, an increase of 157.1% from the September 15th total of 700 shares. Based on an average daily volume of 4,500 shares, the short-interest ratio is presently 0.4 days.

Shares of IBER stock traded up $0.02 during trading hours on Thursday, hitting $9.70. 14,900 shares of the company were exchanged, compared to its average volume of 2,006. The company’s fifty day moving average price is $9.68. Ibere Pharmaceuticals has a 52-week low of $9.60 and a 52-week high of $9.95.

Ibere Pharmaceuticals Company Profile

Ibere Pharmaceuticals focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. The company was founded in 2020 and is based in Philadelphia, Pennsylvania.

Further Reading: What is the QQQ ETF?

Receive News & Ratings for Ibere Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ibere Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.